Metagen Therapeutics and Nippon Life Insurance Tsuruoka Office Sign Second Fecal Donation Promotion Agreement
NQ Score
69/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Metagen Therapeutics Inc. and the Tsuruoka Office of Nippon Life Insurance Company's Yamagata Branch signed their second 'Fecal Donation Promotion Agreement' on May 13, 2026. The agreement aims to promote 'fecal donation' in the Shonai region of Yamagata Prefecture for drug development using gut bacteria. Based on the agreement, Nippon Life will secure opportunities for its employees to donate and conduct awareness activities, while Metagen Therapeutics will provide free seminars on gut health. Together, they will strive to improve community health awareness and establish a new culture of social contribution.